The use of phospholipase C in the study of receptors for neuromuscular blocking agents.
D000818:Animals; D001905:Botulinum Toxins / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D003472:Curare / Q000494:pharmacology; D003964:Diaphragm / Q000294:innervation; D006426:Hemicholinium 3 / Q000494:pharmacology*; D007531:Isoflurophate / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010740:Phospholipases / Q000494:pharmacology*; D010743:Phospholipids / Q000502:physiology; D010791:Phrenic Nerve / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D014403:Tubocurarine / Q000494:pharmacology*
D010743:Phospholipids; D011955:Receptors, Drug; D007531:Isoflurophate; D006426:Hemicholinium 3; D003472:Curare; D010830:Physostigmine; D010740:Phospholipases; D001905:Botulinum Toxins; D014403:Tubocurarine